Financial reports
ARS
2023 FY
Annual report to shareholders
25 Apr 24
10-K
2023 FY
Annual report
7 Feb 24
10-Q
2023 Q3
Quarterly report
30 Oct 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
26 Apr 23
10-K
2022 FY
Annual report
7 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
Current reports
8-K
Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results
6 Feb 24
8-K
Deciphera Pharmaceuticals Announces Planned 2024 Corporate Milestones Supporting Evolution to a Self-Sustaining, Multi-Product Company
8 Jan 24
8-K
Deciphera Pharmaceuticals Announces Third Quarter 2023 Financial Results
30 Oct 23
8-K
Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results
9 Aug 23
8-K
Deciphera Pharmaceuticals Announces Retirement of Daniel L. Flynn, Ph.D., and Appointment of
3 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
22 Jun 23
8-K
Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results
3 May 23
8-K
Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results
7 Feb 23
8-K
Entry into a Material Definitive Agreement
20 Jan 23
8-K
Other Events
18 Jan 23
Registration and prospectus
S-8
Registration of securities for employees
7 Feb 24
S-3ASR
Automatic shelf registration
3 May 23
S-8
Registration of securities for employees
7 Feb 23
424B5
Prospectus supplement for primary offering
20 Jan 23
424B5
Prospectus supplement for primary offering
18 Jan 23
S-3
Shelf registration
4 Aug 22
424B5
Prospectus supplement for primary offering
27 Apr 22
424B5
Prospectus supplement for primary offering
26 Apr 22
S-8
Registration of securities for employees
9 Feb 22
POS AM
Prospectus update (post-effective amendment)
8 Feb 22
Proxies
DEFA14A
Additional proxy soliciting materials
25 Apr 24
DEF 14A
Definitive proxy
25 Apr 24
PRER14A
Preliminary revised proxy
22 Apr 24
PRE 14A
Preliminary proxy
11 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
DEFA14A
Additional proxy soliciting materials
26 Apr 22
DEF 14A
Definitive proxy
26 Apr 22
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
Other
UPLOAD
Letter from SEC
2 Jan 24
CORRESP
Correspondence with SEC
22 Dec 23
UPLOAD
Letter from SEC
14 Dec 23
EFFECT
Notice of effectiveness
11 Aug 22
CORRESP
Correspondence with SEC
8 Aug 22
UPLOAD
Letter from SEC
5 Aug 22
EFFECT
Notice of effectiveness
11 Mar 22
UPLOAD
Letter from SEC
9 Nov 21
CORRESP
Correspondence with SEC
2 Nov 21
UPLOAD
Letter from SEC
27 Oct 21
Ownership
4
Change in insider ownership
24 Apr 24
4
Matthew L Sherman
20 Feb 24
4
Thomas Patrick Kelly
20 Feb 24
4
Jama Pitman
20 Feb 24
4
Steven L. Hoerter
20 Feb 24
4
Dashyant Dhanak
20 Feb 24
4
Daniel C. Martin
20 Feb 24
SC 13G/A
Redmile Group, LLC
14 Feb 24
SC 13G/A
BRAIDWELL LP
14 Feb 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24